Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
NCT03501706 · View on ClinicalTrials.gov ↗
Study Summary
Many health-relevant decisions involve intertemporal (now vs. later) tradeoffs. Extensive literature indicates that many negative health and financial consequences suffered in mid-life are linked to adversity and disadvantage during early developmental periods of life. Individuals who continue to engage in these types of unhealthy behaviors despite awareness of the health consequences are exhibiting an inability to delay gratification. Delay discounting (DD) is quantified in human studies by determining the rate at which an individual discounts a delayed reward, while executive function (EF) is defined as the set of cognitive processes that are responsible for helping individuals manage life tasks and achieve goals. This research will attempt to reduce DD via EF training in a population of mid-life individuals with risk factors established during early-life disadvantage.
Conditions Studied
Interventions
- BEHAVIORAL Sequenced Recall of Digits--Auditory
- BEHAVIORAL Sequenced Reverse Recall of Digits--Auditory
- BEHAVIORAL Sequenced Recall of Words--Visual
- BEHAVIORAL Verbal Memory--Visual
Study Locations (1)
Maryland
- University of Kansas-Lawrence — Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 680 participants |
| Start Date | 2014-11-01 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03501706
The ClinicalTrials.gov registry entry for NCT03501706 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 680 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas, which has 23 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Delay Discounting appearing as the primary indexed condition, and to 4 interventions — of which Sequenced Recall of Digits--Auditory is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03501706 reports 1 study location spanning 1 distinct geographic area — top geographies include Maryland. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03501706 about?
NCT03501706 is a clinical study titled "An Assessment of Cognitive Improvement Training Among Mid-life Individuals". Many health-relevant decisions involve intertemporal (now vs. later) tradeoffs. Extensive literature indicates that many negative health and financial consequences suffered in mid-life are linked to adversity and disadvantage during early developmental periods of life. Individuals who continue to en...
What is the current status of trial NCT03501706?
This trial is currently recruiting. It is a NA study. The enrollment target is 680 participants. The study started on 2014-11-01. Estimated completion is 2024-07-31.
What conditions does trial NCT03501706 study?
This clinical trial studies the following conditions: Delay Discounting. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT03501706?
The interventions under investigation include: Sequenced Recall of Digits--Auditory (BEHAVIORAL), Sequenced Reverse Recall of Digits--Auditory (BEHAVIORAL), Sequenced Recall of Words--Visual (BEHAVIORAL), Verbal Memory--Visual (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT03501706?
This trial is sponsored by University of Kansas, which has 23 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03501706 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.